Knockdown of the stem cell marker Musashi-1 inhibits endometrial cancer growth and sensitizes cells to radiation

Overview of attention for article published in Stem Cell Research & Therapy, May 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter: 12 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 14 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 13 X posts from 12 X users, with an upper bound of 12,210 followers.

RT @siTOOLsBiotech: Endometrial cancer is the most common gynecological cancer in Europe. This study focused on identifying potential thera…

10 Jun 2022

Reply Repost Favourite

RT @siTOOLsBiotech: Endometrial cancer is the most common gynecological cancer in Europe. This study focused on identifying potential thera…

10 Jun 2022

Reply Repost Favourite

Endometrial cancer is the most common gynecological cancer in Europe. This study focused on identifying potential therapeutic effects of Msi-1 knockdown to inhibit #EndometrialCancer growth. Thank you for using #siPOOLs for knockdown of p21 and Msi-1! 📃: h

10 Jun 2022

Reply Repost Favourite

RT @GotteProf: New paper @UK_Muenster Knockdown of the #stemcell marker Musashi-1 inhibits #endometrialcancer growth and sensitizes cells t…

31 May 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.